Lund-based Paindrainer announced recently they have raised €550.000 (SEK 6 million) from existing shareholder Almi Invest and Tramontane Invest, alongside a committed group of existing and new shareholders.
Paindrainer is a digital therapeutics (DTx) company developing digital platforms and applications contributing to health and well-being. PD Care System is the first evidence based digital tool demonstrating improved quality of life in patients suffering from chronic pain.
“Having completed a share issue transaction in the current market with support from both existing and new owners feels fantastic. It shows the growing interest in these types of third-generation digital companies, and it enables us to continue our highly important commercialization and start to grow our operations”
says Erik Frick, CEO Paindrainer.
The solution is powered by a proprietary Artificial Neural Network (ANN) and is fully adaptive to each chronic pain patient, demonstrating our unique and patented 360 patient-centricity concept. Key concepts of this device has now been implemented into an agentic AI powering our newest product, Relivra, that will reach the market during Q2 2026.
The use of proceeds focuses on Paindrainer continued successful commercial rollout in the US of the unique drug-free, digital remote therapeutic monitoring system for chronic pain patients, using the proprietary AI powered neural network. It also enables the company to commercialize the newest product, Relivra, directed to pain Organization in a number of selected markets.
